Back

AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

European Heart Journal - Cardiovascular Pharmacotherapy

10 March 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY

Contributors

Felice Gragnano
Felice Gragnano

Author

The University of Campania Luigi Vanvitelli Caserta , Italy

Arturo Cesaro
Arturo Cesaro

Author

Mattia Galli
Mattia Galli

Author

Paolo Calabrò
Paolo Calabrò

Author

Hospital Sant'anna E San Sebastiano Caserta , Italy

You may be interested in
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Pulmonary hypertension & acute arrhythmias are cardiac care challenges. How to effectively treat them with drugs

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources